Calcium antagonist verapamil prevented pulmonary arterial hypertension in broilers with ascites by arresting pulmonary vascular remodeling

European Journal of Pharmacology

Volumn 561, Issue 1-3, 2007, Pages 137-143

  Yang, Ying ^a   Qiao, Jian ^b   Wang, Huiyu ^b   Gao, Mingyu ^b   Ou, Deyuan ^b   Zhang, Jianjun ^b   Sun, Maohong ^b   Yang, Xin ^a   Zhang, Xiaobo ^a   Guo, Yuming ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b CAU   (China)

Author keywords

Broilers; Calcium antagonists; Pulmonary arterial hypertension; Pulmonary vascular remodeling; Verapamil

Indexed keywords

CALCIUM ANTAGONIST; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; BLOOD VESSEL REMODELING; BROILER CHICKEN; CALCIUM ANTAGONISM; CALCIUM SIGNALING; CHICKEN; CONTROLLED STUDY; ERYTHROCYTE VOLUME; HEART INDEX; HYPERTENSION; LONG TERM CARE; LOW DRUG DOSE; LUNG BLOOD VESSEL; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ANIMALS; ASCITES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CHICKENS; ERYTHROCYTES; HEART RATE; HEMATOCRIT; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; PULMONARY ARTERY; TEMPERATURE; VERAPAMIL;

EID: 33947212857     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.036     Document Type: Article

References (36)

1. Barth P.J., Kimpel C., and Roy S. An improved mathematical approach for the assessment of the medial thickness of pulmonary arteries. Pathol. Res. Pract. 189 (1993) 567
2. Barth P.J., Muller B., Wagner U.L., and Bittinger A. Quantitative analysis of parenchymal and vascular alterations in NO2-induced lung injury in rats. Eur. Respir. J. 8 (1995) 1115-1121
3. Brundel B.J., Kampinga H.H., and Henning R.H. Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc. Res. 62 (2004) 521-528
4. Costa S.K., Moreno H.J., Brain S.D., De Nucci G., and Antunes E. The effect of Phoneutria nigriventer (armed spider) venom on arterial blood pressure of anaesthetised rats. Eur. J. Pharmacol. 298 (1996) 113-120
5. Cubeddu L.X., Aranda J., Singh B., Klein M., Brachfeld J., Freis E., Roman J., and Eades T. Comparison of verapamil and propranolol for the initial treatment of hypertension: racial differences in response. JAMA 256 (1986) 2214-2221
6. Currie R.J. Ascites in poultry: recent investigations. Avian Pathol. 28 (1999) 313-326
7. Dacquet C., Mironneau C., and Mironneau J. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein. Br. J. Pharmacol. 92 (1987) 203-211
8. 2+ release and ATP-dependent facilitation of arterial myocyte contraction. Proc. Natl. Acad. Sci. 103 (2006) 4316-4321
9. Egan C.G., and Nixon G.F. Endothelin-1 and depolarization-induced differential regulation of cAMP response element-binding protein in proliferating and developed vascular smooth muscle. Cell. Signal. 16 (2004) 1387-1396
10. Enkvetchakul B., Beasley J., and Bottje W. Pulmonary arteriole hypertrophy in broilers with pulmonary hypertension syndrome (ascites). Poult. Sci. 74 (1995) 1677-1682
11. Grossman E., and Messerli F.H. Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure. Am. J. Cardiol. 80 (1997) 1453-1458
12. Guthrie A.J., Cilliers J.A., Huchzermeyer F.W., and Killeen V.M. Broiler pulmonary hypertension syndrome. II. The direct measurement of right ventricular and pulmonary artery pressures in the closed chest domestic fowl. Onderstepoort J. Vet. Res. 54 (1987) 599-602
13. Hernandez-Hernandez R., Velasco M., Armas-Hernandez M.J., and Armas-Padilla M.C. Use of calcium antagonists in hypertension. Int. Congr. Ser. 1237 (2002) 109-117
14. Hu Q.H., and Wang D.X. Both hypoxic endothelial cell conditioned medium and hypoxia elevate intracellular free calcium in pulmonary artery smooth muscle cells. J. Tongji Med. Univ. 14 (1994) 200-203
15. Julian R.J. Ascites in poultry. Avian Pathol. 22 (1993) 419-454
16. Lay C.S., May C.M., Lee F.Y., Tsai Y.T., Lee S.D., Chien S., and Sinchon S. Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: role of prostaglandin. World J. Gastroenterol. 12 (2006) 2351-2356
17. Liu C.Y., and Sturek M. Attenuation of endothelin-1-induced calcium response by tyrosine kinase inhibitors in vascular smooth muscle cells. Am. J. Physiol. 270 (1996) C1825-C1833
18. Mandegar M., Remillard C.V., and Yuan J.X. Ion channels in pulmonary arterial hypertension. Prog. Cardiovasc. Dis. 45 (2002) 81-114
19. Mandegar M., Fung Y.C., Huang W., Remillard C.V., Rubin L.J., and Yuan J.X. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc. Res. 68 (2004) 75-103
20. Morley P., Hogan M.J., and Hakim A.M. Calcium mediated mechanisms of ischemic injury and protection. Brain Pathol. 4 (1994) 37-47
21. 2+ influx. J. Mol. Cell Cardiol. 28 (1996) 707-722
22. Pereira L.M., Bezerra D.G., and Mandarim-de-Lacerda C.A. Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil. Pathol. Res. Pract. 200 (2004) 211-217
23. Pietra G.G., Edwards W., Kay J., Rich S., Kernis J., Schloo B., Ayres S., Bergofsky E., Brundage B., and Detre K. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 80 (1989) 1198-1206
24. Pitt B. Diversity of calcium antagonists. Clin. Ther. 19 (1997) 3-17
25. Shimoda L.A., Sham J.S., and Sylvester J.T. Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol. Res. 49 (2000) 549-560
26. 2+ by endothelin-1 in rat intrapulmonary arterial smooth muscle cells. Am. J. Physiol., Lung Cell. Mol. Physiol. 278 (2000) L157-L164
27. Shlosberg A. The effects of poor ventilation, low temperatures, type of feed and sex of bird on development of ascites in broiler. Physiopathological factors. Avian Pathol. 21 (1992) 369-382
28. Siesjo B. Calcium and cell death. Magnesium 8 (1989) 223-237
29. Singh B.N., Ellrodt G., and Peter C.T. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs 15 (1978) 169-197
30. 2+ concentration during hypoxia in single Xenopus skeletal myocytes. Exp. Physiol. 88 (2003) 415-421
31. 2+ Release. Pediatr. Res. 60 (2006) 258-263
32. Wamhoff B.R., Bowles D.K., and Owens G.K. Excitation-transcription coupling in arterial smooth muscle. Circ. Res. 98 (2006) 868-878
33. Wang X., Ohnishi M., Wada A., Tsutamoto T., Sawaki M., Fujii M., Matsumoto T., Yamamoto T., Kurokawa K., Yamada H., and Kinoshita M. Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor. Life Sci. 69 (2001) 2477-2488
34. Wideman R.F.J., Ismail M., Kirby Y.K., Bottje W.G., Moore R.W., and Vardeman R.C. Furosemide reduces the incidence of pulmonary hypertension syndrome (ascites) in broilers exposed to cool environmental temperatures. Poult. Sci. 74 (1995) 314-322
35. Widimsky J., and Herget J. Pulmonary blood vessels in lung disease. Prog. Respir. Res. 26 (1990) 12-28
36. Yang Y., Qiao J., Wu Z., Chen Y., Gao M., Ou D., and Wang H. Endothelin-1 receptor antagonist BQ123 prevents pulmonary artery hypertension induced by low ambient temperature in broilers. Biol. Pharm. Bull. 28 (2005) 2201-2205